Express Pharma - Page 1847 of 2181 - Express Pharma

Lupin receives Great Place To Work certification across global operations

CuraTeQ Biologics reports Phase 3 results for BP11 biosimilar to Xolair

Bayer revises access model for Eylea 2mg in India to expand patient eligibility

‘Prioritise IP rights, to create a constant cycle of innovation that will help sustain India’s economy’

‘Main focus should be on developing a mass-based health insurance system’

‘Set up fast track courts to address IPR disputes’

‘New government should get its regulatory role restored’

Glenmark opens antibody manufacturing facility in Switzerland

Indian consumers lack awareness on medical devices: AdvaMed

Focus on cross-border deals

Evolva joins forces with Malaysian University

US FDA approves first generic versions of celecoxib

BMS and Syngene International in collaboration